Trials / Completed
CompletedNCT01054781
Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)
Open-labelled, Multicenter Phase II Study of Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the complete response (CR) rate after Intensified 1st cycle Rituximab plus 3rd cycles of R-CHOP in DLBCL
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rituximab | 1st cycle R+R-CHOP 2-8th cycle R-CHOP |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-11-01
- First posted
- 2010-01-22
- Last updated
- 2012-09-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01054781. Inclusion in this directory is not an endorsement.